According to a report from Newsis in Seoul on October 23, Philip Morris Products S.A., the Swiss headquarters of PMI, has applied to register the trademarks "VEEV One Ultra" and "VEEV Now Ultra" at the Korean Patent Office. However, there has not been any confirmed information about the product's launch in the South Korean market. There is considerable interest from various sectors about whether PMI's e-cigarette, the "IQOS VEEV," will make an impact in the Korean tobacco market.
The IQOS VEEV has gained a wide consumer base worldwide and is currently being sold in over ten countries including Canada, Croatia, Czech Republic, Finland, France, Greece, Italy, Ukraine, and New Zealand. However, it remains uncertain whether this product will be introduced in the South Korean market.
South Korean company KT&G previously launched a similar e-cigarette product called Real Viper in 2019 but ceased its sales the following year. Tobacco company JUUL, which holds a 70% share of the e-cigarette market in the United States, made an unsuccessful attempt in the Korean market for a year before ultimately withdrawing in 2020.
Previously, British American Tobacco launched the vape brand "Vuse Go 800" but it was only available in the Seoul metropolitan area. As it is customary to apply for trademark registration with the Korean Intellectual Property Office before launching a new product, some speculate that "IQOS VEEV" is about to be introduced. PMI has already introduced products in the vape market, which is mature in the United States and Europe. If PMI enters the vape market, it is expected that the e-cigarette market centered around cigarette-shaped e-cigarettes in the country will undergo changes. However, a representative from PMI Korea stated, "It has not yet been confirmed whether we will launch 'IQOS VEEV' in the Korean market.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
